Immunic IMUX Cash Flow Statement (2013-2026)

NASDAQ IMUX
$12.78 +0.02 (+0.20%)
As of: Sep 4, 2026 · 2:23 PM EDT
Reported Financials

Immunic Quarterly Cash Flow Statement

Periods 54 quarters
Latest Jun 2026

Immunic reported cash from operations of -$31.00M and free cash flow of -$31.25M for the quarter ended Jun 2026, down 26.0% year over year. This cash flow statement covers 54 quarters of results from Mar 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-18.38M-21.71M-21.43M-20.50M-19.89M-56.63M-26.45M-24.05M-22.80M-22.84M-22.69M-21.82M-24.95M-25.20M-26.64M-26.84M-25.57M-23.13M-32.48M-34.04M
Share-based Compensation
1,397.00M2.07M2,062.00M1,912.00M1.89M1.98M1,798.00M1,687.00M1.64M2.75M1,882.00M1,910.00M1.99M2.04M1.90M3,614.00M1.31M4.47M6.78M
Asset Writedowns and Impairment
Cash from Operations
-17.60M-23.68M-20.68M-15.76M-13.60M-15.10M-19.51M-19.98M-17.31M-14.03M-23.97M-17.04M-20.80M-22.96M-21.78M-24.61M-20.14M-19.28M-17.30M-31.00M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Depreciation & Amortization
0.02M0.04M0.02M0.02M0.02M0.02M0.03M0.02M0.03M0.02M0.03M0.03M0.04M0.04M0.04M0.04M0.04M0.04M0.03M0.03M
Change in Working Capital
Change in Account Payables
-0.74M0.44M-0.35M1.18M0.33M-0.35M0.99M-0.54M-1.40M1.77M1.79M1.18M-2.11M2.27M-2.08M1.19M-0.03M2.16M1.09M1.77M
Change in Accured Expenses
-0.30M0.41M0.56M-1.42M1.33M0.90M2.07M2.39M1.50M4.32M-6.14M1.73M2.52M-2.96M4.71M-1.26M1.43M-0.40M4.21M-4.53M
Other Working Capital Changes
-2.38M6.50M2.27M-2.41M-1.92M-5.43M-0.12M-0.19M-3.57M0.02M-0.39M0.01M-1.08M-0.43M0.84M-0.41M-0.60M3.33M-5.21M0.72M
Investing Activities
Capital Expenditures
0.02M0.02M0.01M0.03M0.07M-0.00M0.10M0.02M0.04M0.17M0.03M0.18M0.05M0.00M0.05M0.04M0.07M0.01M0.00M0.25M
Sales of Property, Plant and Equipment
Change in Acquisitions & Divestments
5.44M4.36M
Cash from Investing Activities
-0.02M-0.02M-0.01M-0.03M-0.07M-9.63M5.33M4.34M-0.04M-0.17M-0.03M-0.18M-0.05M-0.00M-0.05M-0.04M-0.07M-0.01M-0.00M-0.25M
Financing Activities
Other financing activities
0.09M0.01M0.12M0.05M0.05M0.04M0.03M0.08M0.12M0.06M187.26M
Debt Issuance and Repayment
Long-Term Debt Issuances
74.27M60.66M
Change in Capital Stock
Net Shares Issued and Repurchased
Net Equity Issued and Repurchased
42.02M29.64M10.00M16.41M0.30M0.57M0.19M
Misc.
Cash from Financing Activities
42.02M0.82M29.64M10.08M56.04M0.05M0.10M0.28M0.60M74.46M0.08M65.52M0.06M188.64M0.12M
Exchange Rate Effect
-1.13M-0.70M-0.10M-1.92M-1.64M2.67M0.14M0.08M-0.53M0.57M0.17M-0.40M0.22M-0.51M0.46M0.13M0.03M-0.42M-0.19M-0.40M
Change in Cash
23.27M-23.58M8.85M-7.63M-15.31M33.97M-13.98M-15.47M-17.61M-13.02M50.64M-17.61M-20.63M-23.40M-21.36M41.01M-20.18M-19.65M171.15M-31.53M
Free Cash Flow
-17.62M-23.70M-20.69M-15.79M-13.67M-15.10M-19.62M-20.00M-17.36M-14.19M-24.00M-17.22M-20.84M-22.97M-21.82M-24.64M-20.21M-19.29M-17.30M-31.25M
Net Cash Flow
24.40M-22.88M8.95M-5.71M-13.67M31.31M-14.13M-15.54M-17.07M-13.59M50.46M-17.22M-20.84M-22.89M-21.82M40.87M-20.21M-19.23M171.34M-31.13M